Quantcast
Last updated on April 16, 2014 at 7:25 EDT

Latest Nephros Inc. Stories

2014-03-28 16:22:51

RIVER EDGE, N.J., March 28, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three months and full year ended December 31, 2013. 2013 Highlights -- Total water filter sales increased by 23% from $1,005,000 in 2012 to...

2014-03-24 16:24:57

RIVER EDGE, N.J., March 24, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today the successful completion of its rights offering. Nephros received gross proceeds of $2.14 million from the rights offering. A portion of the proceeds was used for the repayment of...

2014-03-11 16:26:49

RIVER EDGE, N.J., March 11, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and a Hemodiafiltration system for the treatment of chronic renal failure patients today provided an update on its operations and strategy. Recent Highlights -- Daron Evans appointed to Board of Directors -- Launched NanoGuard-D and NanoGuard-S ultrafilters for filtration of water...

2014-03-11 16:26:38

RIVER EDGE, N.J, March 11, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and Mar Cor Purification, a wholly owned subsidiary of Cantel Medical Corp., announced today that the companies have signed a non-exclusive distributor agreement to distribute Nephros's dialysis ultrafilters to U.S. and Canadian dialysis clinics. Curtis Weitnauer, President and Chief Executive Officer...

2014-02-25 20:21:53

RIVER EDGE, N.J., Feb. 25, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and Bellco S.r.l., an Italy-based company focused on Dialysis and Extracorporeal Blood Purification, announced today that the companies have signed an amendment to their existing license agreement. The amendment extends the agreement by five years through 2021 and expands the territories covered by...

2014-02-12 20:21:55

RIVER EDGE, N.J., Feb. 12, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today that it has commenced its previously disclosed rights offering. On February 12, 2014, the Company will distribute to holders of its common stock and/or warrants one non-transferable subscription right for each share of common stock, and each share of common stock underlying a warrant,...

2013-11-29 16:21:34

RIVER EDGE, N.J., Nov. 29, 2013 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today the appointment of Daron Evans to its Board of Directors. Mr. Evans replaces James S. Scibetta who will be leaving the Board effective December 31, 2013. Mr. Evans was also named a member of the Audit Committee. Mr. Evans is a life sciences executive with over 20 years of...

2013-11-14 16:29:04

RIVER EDGE, N.J., Nov. 14, 2013 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today financial results for the three and nine months ended September 30(th) 2013 and that the company entered into a bridge loan and security agreement with Lambda Investors LLC, an affiliate of Wexford Capital LP and the company's largest shareholder. Financial Performance for...

2013-08-13 16:26:50

RIVER EDGE, N.J., Aug. 13, 2013 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced financial results for the three and six months ended June 30, 2013. Recent Highlights -- 196% increase in water filter sales Q2 2013 versus Q2 2012 -- Completed Rights Offering and Temporary Reduction in Exercise Price for March 2011 Warrants -- Complete...

2013-05-23 16:26:33

RIVER EDGE, N.J., May 23, 2013 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today the successful completion of its rights offering. In addition, the concurrent temporary reduction in exercise price for the company's March 2011 warrants expired on May 17, 2013. Nephros estimates that it will receive gross proceeds of $3.0 million from the rights offering....